skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Pharmacokinetics of rhodanese-thiosulfate loaded murine carrier erythrocytes

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:7080605

Since the therapeutic potential of murine erythrocytes employed in the encapsulation of rhodanese as a cyanide detoxification mechanism is dependent on a prolong circulatory lifespan, in vivo survival studies were initiated in normal adult Balb/c mice. After a single intravenous administration of the /sup 14/C-sucrose loaded carrier erythrocytes, radioactive analyses in whole blood indicated a biexponential decay. Initially, a rapid decline in /sup 14/C-sucrose radioactivity in whole blood (t/sub 1/2/ = 23 minutes) is followed by a slower decline with an apparent t/sub 1/2/ of 11 days. In contrast, when /sup 14/C-sucrose was not encapsulated, greater than 90% was eliminated from the circulation within 10 minutes. Leakage of /sup 14/C-sucrose out of the carrier erythrocytes is minimal, since less than 2% of the initial dose of encapsulated /sup 14/C-sucrose appear in plasma. When rhodanese-loaded carrier erythrocytes was employed, a similar survival curve was observed. In summary, these results suggest that carrier erythrocytes represent a viable alternative approach for the detoxification of exogenous chemical toxicants.

Research Organization:
Texas A and M Univ., College Station
OSTI ID:
7080605
Report Number(s):
CONF-8604222-; TRN: 87-009087
Journal Information:
Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States), Vol. 45:4; Conference: 70. annual meeting of the Federation of American Society for Experimental Biology, St. Louis, MO, USA, 13 Apr 1986
Country of Publication:
United States
Language:
English